Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases

NCT05481658 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Metastases

Interventions

DRUG: Diphencyprone (DPCP)

Sponsor

Nicholas Gulati